COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Group 1 - CollPlant Biotechnologies will report its financial results for Q1 2024 on May 29, 2024, before U.S. market opening [1] - A conference call and webcast will be held on May 29 at 10:00 a.m. EDT to discuss financial results and corporate updates [1] - The company specializes in regenerative and aesthetic medicine, focusing on non-animal-derived collagen for tissue regeneration [5] Group 2 - CollPlant's products are based on rhCollagen produced through proprietary plant-based genetic engineering technology [5] - The company has a development and commercialization agreement with Allergan for dermal and soft tissue fillers, enhancing its position in the market [6]